Prevalence of Anemia in Chronic Kidney Disease in the United States

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Jan 7

PMID 24392162

Citations 269

Authors

Melissa E Stauffer

Tao Fan

Affiliations

Soon will be listed here.

Abstract

Anemia is one of the many complications of chronic kidney disease (CKD). However, the current prevalence of anemia in CKD patients in the United States is not known. Data from the National Health and Nutrition Examination Survey (NHANES) in 2007-2008 and 2009-2010 were used to determine the prevalence of anemia in subjects with CKD. The analysis was limited to adults aged >18 who participated in both the interview and exam components of the survey. Three outcomes were assessed: the prevalence of CKD, the prevalence of anemia in subjects with CKD, and the self-reported treatment of anemia. CKD was classified into 5 stages based on the glomerular filtration rate and evidence of kidney damage, in accordance with the guidelines of the National Kidney Foundation. Anemia was defined as serum hemoglobin levels ≤12 g/dL in women and ≤13 g/dL in men. We found that an estimated 14.0% of the US adult population had CKD in 2007-2010. Anemia was twice as prevalent in people with CKD (15.4%) as in the general population (7.6%). The prevalence of anemia increased with stage of CKD, from 8.4% at stage 1 to 53.4% at stage 5. A total of 22.8% of CKD patients with anemia reported being treated for anemia within the previous 3 months-14.6% of patients at CKD stages 1-2 and 26.4% of patients at stages 3-4. These results update our knowledge of the prevalence and treatment of anemia in CKD in the United States.

Citing Articles

Relationship of sKlotho with hemoglobin level in patients undergoing maintenance hemodialysis: a case-control study.

Liu Q, Sun Z, Tang X, Yu L, Li S Ther Adv Chronic Dis. 2025; 16:20406223251318481.

PMID: 39959415 PMC: 11829302. DOI: 10.1177/20406223251318481.

Highlights on U.S. FDA-approved halogen-containing drugs in 2024.

Ali S, Tian X, Meccia S, Zhou J Eur J Med Chem. 2025; 287:117380.

PMID: 39947048 PMC: 11846695. DOI: 10.1016/j.ejmech.2025.117380.

Prevalence and Treatment Patterns of Anaemia in Individuals With Chronic Kidney Disease Across Asia: A Systematic Review and Meta-Analysis.

Kim D, Lee J, Toyama T, Liyanage T, Woodward M, Matsushita K Nephrology (Carlton). 2025; 30(2):e70002.

PMID: 39888116 PMC: 11780214. DOI: 10.1111/nep.70002.

Integrated Longitudinal Population Dose-Hemoglobin Response of Daprodustat Following Dose Titration in Patients With Anemia in Chronic Kidney Disease.

Mahar K, van Noort M, van den Berg P, Yang S, Visser S, Post T Clin Pharmacol Ther. 2025; 117(3):846-856.

PMID: 39876087 PMC: 11835430. DOI: 10.1002/cpt.3544.

Treatment Inertia and Symptom Burden in Anemia of CKD: Insights from the SATISFY Survey in the Middle East, South Africa, and Türkiye.

Arici M, Al-Ghamdi S, Assounga A, El-Koraie A, McMillan A, Camidge L Int J Nephrol Renovasc Dis. 2025; 18:27-42.

PMID: 39866642 PMC: 11766225. DOI: 10.2147/IJNRD.S474716.

References

Coresh J, Selvin E, Stevens L, Manzi J, Kusek J, Eggers P . Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298(17):2038-47. DOI: 10.1001/jama.298.17.2038. View

Lawler E, Gagnon D, Fink J, Seliger S, Fonda J, Do T . Initiation of anaemia management in patients with chronic kidney disease not on dialysis in the Veterans Health Administration. Nephrol Dial Transplant. 2010; 25(7):2237-44. DOI: 10.1093/ndt/gfp758. View

Lenz O, Fornoni A . Chronic kidney disease care delivered by US family medicine and internal medicine trainees: results from an online survey. BMC Med. 2006; 4:30. PMC: 1713248. DOI: 10.1186/1741-7015-4-30. View

. Prevalence of chronic kidney disease and associated risk factors--United States, 1999-2004. MMWR Morb Mortal Wkly Rep. 2007; 56(8):161-5. View

Mehdi U, Toto R . Anemia, diabetes, and chronic kidney disease. Diabetes Care. 2009; 32(7):1320-6. PMC: 2699743. DOI: 10.2337/dc08-0779. View

Agarwal A . Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly. J Am Med Dir Assoc. 2006; 7(9 Suppl):S7-S12. DOI: 10.1016/j.jamda.2006.09.005. View

Bowling C, Inker L, Gutierrez O, Allman R, Warnock D, McClellan W . Age-specific associations of reduced estimated glomerular filtration rate with concurrent chronic kidney disease complications. Clin J Am Soc Nephrol. 2011; 6(12):2822-8. PMC: 3255373. DOI: 10.2215/CJN.06770711. View

Hsu C, McCulloch C, Curhan G . Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol. 2002; 13(2):504-510. DOI: 10.1681/ASN.V132504. View

Rasu R, Manley H, Crawford T, Balkrishnan R . Undertreatment of anemia in patients with chronic kidney disease in the United States: analysis of national outpatient survey data. Clin Ther. 2007; 29(7):1524-34. DOI: 10.1016/j.clinthera.2007.07.016. View

10.

Nissenson A, Wade S, Goodnough T, Knight K, Dubois R . Economic burden of anemia in an insured population. J Manag Care Pharm. 2005; 11(7):565-74. PMC: 10437330. DOI: 10.18553/jmcp.2005.11.7.565. View

11.

van Nooten F, Green J, Brown R, Finkelstein F, Wish J . Burden of illness for patients with non-dialysis chronic kidney disease and anemia in the United States: review of the literature. J Med Econ. 2010; 13(2):241-56. DOI: 10.3111/13696998.2010.484307. View

12.

Coresh J, Astor B, Greene T, Eknoyan G, Levey A . Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2002; 41(1):1-12. DOI: 10.1053/ajkd.2003.50007. View

13.

Coresh J, Byrd-Holt D, Astor B, Briggs J, Eggers P, Lacher D . Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2004; 16(1):180-8. DOI: 10.1681/ASN.2004070539. View

14.

Smith Jr R . The clinical and economic burden of anemia. Am J Manag Care. 2010; 16 Suppl Issues:S59-66. View

15.

Stevens L, Li S, Wang C, Huang C, Becker B, Bomback A . Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2010; 55(3 Suppl 2):S23-33. PMC: 4574484. DOI: 10.1053/j.ajkd.2009.09.035. View

16.

Snyder J, Foley R, Collins A . Prevalence of CKD in the United States: a sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008; 53(2):218-28. PMC: 2664624. DOI: 10.1053/j.ajkd.2008.07.034. View

17.

Stevens L, Li S, Kurella Tamura M, Chen S, Vassalotti J, Norris K . Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2011; 57(3 Suppl 2):S9-16. PMC: 3298760. DOI: 10.1053/j.ajkd.2010.11.007. View

18.

. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis. 2006; 47(5 Suppl 3):S11-145. DOI: 10.1053/j.ajkd.2006.03.010. View

19.

Clase C, Kiberd B, Garg A . Relationship between glomerular filtration rate and the prevalence of metabolic abnormalities: results from the Third National Health and Nutrition Examination Survey (NHANES III). Nephron Clin Pract. 2007; 105(4):c178-84. DOI: 10.1159/000100489. View

20.

Robinson B, Artz A, Culleton B, Critchlow C, Sciarra A, Audhya P . Prevalence of anemia in the nursing home: contribution of chronic kidney disease. J Am Geriatr Soc. 2007; 55(10):1566-70. DOI: 10.1111/j.1532-5415.2007.01389.x. View